Key points are not available for this paper at this time.
Within the context of 3 years of PSEI for subclinical lymphedema, variables of ALND, taxane-based chemotherapy, RNI, body mass index >30, and rurality increased risk.
Koelmeyer et al. (Thu,) studied this question.